Alan Mendelsohn

No open positions remaining

64 year

Health Technology

Consumer Services

Profile

Alan Mendelsohn worked as a Senior Director in Immunology Research & Development at Johnson & Johnson from 2006 to 2014.
He then worked as a Senior Director at Pfizer Inc. from 2014 to 2016.
From 2016 to 2021, he worked as an Associate VP in Dermatology Medical Affairs at Sun Pharmaceutical Industries Ltd. Currently, he is the Chief Medical Officer & Executive Vice President at Timber Pharmaceuticals, Inc. Dr. Mendelsohn earned a doctorate degree from the State University of New York at Downstate Medical Center.

Former positions of Alan Mendelsohn

Companies	Position	End
TREX WIND-DOWN, INC.	Chief Tech/Sci/R&D Officer	2024-01-21
SUN PHARMACEUTICAL INDUSTRIES LTD.	Corporate Officer/Principal	2021-01-31
PFIZER INC.	Director/Board Member	2016-11-30
JOHNSON & JOHNSON	Corporate Officer/Principal	2013-12-31

See the detail of Alan Mendelsohn's experience

Training of Alan Mendelsohn

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alan Mendelsohn's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Johnson & Johnson Johnson & Johnson Operates as an investment holding company with interests in health care products
Pfizer Inc. Pfizer Inc. Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients
Sun Pharmaceutical Industries Ltd. Sun Pharmaceutical Industries Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical ingredients	Health Technology
State University of New York at Downstate Medical Center State University of New York at Downstate Medical Center Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc. Operates as a biopharmaceutical company which develops and commercializes therapies for treatment of orphan dermatologic diseases